U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07059221) titled 'A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer' on July 01.
Brief Summary: The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-A2102 with Adebrelimab with or without other Antitumor Therapy in Subjects with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
To explore the reasonable dosage of SHR-A2102 for n Subjects with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Recurrent/Metastatic Head and Neck Squam...